Aprea Therapeutics
USEntry
2003
Hold
23yr
Status
Active
Who owns Aprea Therapeutics?
Aprea Therapeutics is currently owned by Karolinska Development through Karolinska Development (2003 vintage), since 2003. Across its history, Aprea Therapeutics has been through 3 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-06-30
Most recent investor
Karolinska DevelopmentKarolinska Development · 2003 · Life Sciences VC
3 ownership periods · full history below
Key facts
HQSweden
SectorBiotech
StatusAcquired
Key takeaways
- ·Held by Karolinska Development since 2003 (23Y hold).
- ·Average hold across 2 realized cycles: 5 years.
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2003 · present
Karolinska DevelopmentActive
2003 · present(23yr) · Karolinska Development · 2003 · Life Sciences VC
More from Karolinska Development
Other portfolio companies in the same fund.
Denmark
Sweden
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Aprea Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Aprea Therapeutics?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Aprea Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue